Clinical trial
Comparison of Effectiveness in Patients of Gastroesophageal Reflux Disease Taking Esomeprazole Versus Vonoprazan.
NCT07563491 is registered in ClinicalTrials.gov with Muhammad Aamir Latif as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Effectiveness in Patients of Gastroesophageal Reflux Disease Taking Esomeprazole Versus Vonoprazan.
- Lead sponsor
- Muhammad Aamir Latif
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 1, 2025
- Completion date
- September 30, 2025
- Enrollment
- 824 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastro esophageal reflux